Article
Real-world application of targeted next-generation sequencing for identifying molecular variants in Asian non-small-cell lung cancer
17 Apr 2025
Abstract excerpt
BACKGROUND: The advent of novel therapeutic agents has advanced biomarker characterization in non-small-cell lung cancer (NSCLC), driving increased adoption of next-generation sequencing (NGS) technologies for molecular testing. However, comprehensive data addressing the clinical utility of different NGS platforms for NSCLC remains limited. METHODS: This retrospective study analyzed real-world data from 478...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
